LunarCrush LLM | post/tweet::1946272839956586766

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![ExposeFirst Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1935575442628485120.png) First Expose [@ExposeFirst](/creator/twitter/ExposeFirst) on x XXX followers
Created: 2025-07-18 18:16:19 UTC

📉 GSK shares slide as its blood cancer drug blenrep faces likely rejection from the US FDA.
Despite hopes of revival, regulatory doubts over clinical trial results cast a shadow on approval chances.
📍Investor confidence takes a hit amid growing uncertainty in oncology pipeline.

#GSK #FDA #PharmaNews #Oncology #StockMarket


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946272839956586766/c:line.svg)

**Related Topics**
[stockmarket](/topic/stockmarket)
[investment](/topic/investment)
[revival](/topic/revival)
[stocks](/topic/stocks)

[Post Link](https://x.com/ExposeFirst/status/1946272839956586766)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

First Expose @ExposeFirst on x XXX followers Created: 2025-07-18 18:16:19 UTC

📉 GSK shares slide as its blood cancer drug blenrep faces likely rejection from the US FDA. Despite hopes of revival, regulatory doubts over clinical trial results cast a shadow on approval chances. 📍Investor confidence takes a hit amid growing uncertainty in oncology pipeline.

#GSK #FDA #PharmaNews #Oncology #StockMarket

XXX engagements

Engagements Line Chart

Related Topics stockmarket investment revival stocks

Post Link